Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary

Oncology Institute

28/03/2024 16:33

* Oncology Institute Inc  TOI.OQ  reported a quarterly
adjusted
loss of 21 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -25 cents.  The lone analyst forecast for the
quarter was for a loss of 11 cents per share. 
    * Revenue rose 20.1% to $85.79 million from a year ago;
analysts
expected $82.04 million. 
    * Oncology Institute Inc's reported EPS for the quarter was
a loss
of 21 cents​.
    * The company reported a quarterly loss of $15.31 million.
    * Oncology Institute Inc shares had fallen by 9.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "strong buy"

Wall Street's median 12-month price target for Oncology
Institute Inc is $2.50 
This summary was machine generated from LSEG data March 28 at
04:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.11          -0.21          Missed
 Sep. 30 2023      -0.13          -0.19          Missed
 Jun. 30 2023      -0.17          -0.19          Missed